ATHE is now on watch by Wall Street´s Top Financial Newsletter
- Don't Trade ATHE until you read a Full Report!
- Get Alert's on companies like ATHE BEFORE the Rest.
- Is ATHE a Buy? Receive Exclusive Research and Analysis.
- Find out what ATHE Insiders don't want you to know.
ATHE Stock News
- Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Cl... 05/08/2024 11:25 AM- ATH434-201 Trial on Track to Complete in November 2024 – - Top-Line Data Expected in January 2025 - MELBOURNE, Australia and SAN FRANCISCO, May 08, 2024 (GL...
- Appendix 4C – Q3 FY24 Quarterly Cash Flow Report... 04/30/2024 11:25 AMHighlights ATH434-201 Phase 2 baseline data confirm approach to target biomarkers for slowing disease progressionPresented promising nonclinical data on ATH434 ...
- Alterity Therapeutics Presents New Data Demonstrating Potential of ATH434 to Tre... 04/29/2024 11:25 AM– New Evidence Indicates ATH434 can Function as an Iron Chaperone to Redistribute Iron – MELBOURNE, Australia and SAN FRANCISCO, April 29, 2024 (GLOBE NEWSW...
- Alterity Therapeutics Parkinson’s Disease and Multiple System Atrophy Data Fea... 04/17/2024 11:25 AM– ATH434 Improved Motor Performance and General Function in a Primate Model of Parkinson’s Disease – – ATH434-201 Phase 2 Baseline Data Confirm Approach...
- Alterity Therapeutics to Present New Data on ATH434 at the World Orphan Drug Con... 04/10/2024 11:25 AMMELBOURNE, Australia and SAN FRANCISCO, April 10, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”),...
FIND OUT WHY WE ARE THE #1 FINANCIAL NEWSLETTER ON THE INTERNET TODAY!
If the Stock Market were the United States, there is no doubt that the Penny Stock Market would be considered the Wild West.
There is no doubt the Penny Stock Market has turned average investors into millionaires.
However, many Investors have fallen prey to the bad newsletters, irresponsible companies, manipulative market makers and more. Well….Its time to FIGHT BACK!
Stop guessing, praying, and hoping your stock hits the jackpot! Every trader needs an advantage and the right tools, and that’s where we come in.
At WallStreetObserver.com, you won’t hear us tell you that we’ll make you rich.
FORGET ALL THOSE GIMMICKS AND GET RICH SCHEMES!
THE WALLSTREETOBSERVER.COM DIFFERENCE
- In Depth Alerts on Explosive Penny Stocks instantly via Email, Text Message & Social Media BEFORE the rest of Wall Street catches on!
- Exclusive Fundamental and Technical Chart Analysis – not just empty promises of big gains!
- Alerts from all Sectors including Oil, Gold, Green Energy, Biotech, Legal and Medical MJ, Pharmaceutical Biotech Stocks set for FDA Decision, and more!
- Both Uncompensated & Compensated Stocks currently going through marketing campaigns!
- Our Exclusive Trading School tailored just for trading the Penny Stock market to help you become a better trader!
How It Works
Leading Penny Stock Alert Provider
Recent Winners
“It takes 20 years to build a reputation and five minutes to ruin it. If you think about that you’ll do things differently.”
- Legendary Investor, Warren Buffett
Our track record is our reputation. And you can be sure we don’t take it lightly. That’s why we strive to be the To Financial Newsletter on the Street Today.